That perfect Southern California sunset. The palm trees. The Los Angeles skyline. The unmatched energy of the beautiful game. Those things — more like feelings, really — inspired one LA-based artist ...

Spring at UC Davis is a season of transition. Students are already eagerly registering for commencement, and just a few weeks ...

Penn State Altoona will hold poster presentation workshops for students already registered for or interested in participating in the Undergraduate Research and Creative Activities Fair. Students may ...

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

School posters don’t have to start with scissors, glue sticks, and a trifold board on the floor. PowerPoint in Microsoft 365 offers a simple way to design clean, professional posters using tools many ...

The 2026 RBMS Conference Program Planning Committee is issuing a second call for proposals for virtual and short-form content for the 2026 conference titled Advocacy: Finding Your Voice, June 23-26, ...

Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO-GI, AACR-IO, ESMO-TAT, ICNHO, and WOC TAIPEI and SHANGHAI and SAN ...

CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American ...

“These abstract acceptances underscore the growing scientific and clinical interest in PALI-2108 and its differentiated, gut-targeted approach to treating ulcerative colitis,” said Dr. Mitchell Jones, ...

Presenter: Michael Gazda, Ph.D. The abstracts are scheduled to be posted to the ASCO GI Online Program at 5 PM ET on Monday, January 6. About BXQ-350 Bexion's lead drug candidate is BXQ-350, a ...

Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist’s proprietary discovery platform are currently in advanced ...